Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2010

01.01.2010 | Clinical trial

Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node

verfasst von: Andraž Perhavec, Maja Pohar Perme, Marko Hočevar, Nikola Besić, Janez Žgajnar

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Several tools for predicting the likelihood of non-sentinel lymph node (non-SLN) involvement in SLN-positive breast cancer patients have been created so far. The aim of our study was to create and validate different nomograms for predicting the likelihood of non-SLN involvement that would be applicable in different institutions and that would also include the results of the preoperative US examination of the axilla. From January 2000 to January 2009, 534 breast cancer patients underwent axillary lymph node dissection (ALND) due to metastatic SLN at our institution. Using logistic regression results three nomograms differing in the inclusion of the results of intraoperative examination of SLN were created. The nomograms were validated using bootstrap methods. In all three nomograms, US examination of the axilla was a powerful independent variable. Other variables included (different in different nomograms) were tumor size, lymphovascular invasion, metastasis size in SLN, number of negative and number of positive SLNs. Mean absolute error and mean area under the ROC curve equals to 0.016 and 0.77 for the first, 0.023 and 0.75 for the second and 0.014 and 0.79 for the third nomogram. Three nomograms for predicting the likelihood of non-SLN metastases including the results of the preoperative US examination of the axilla were created at our institution. They differ in the inclusion of the results of intraoperative examination of SLNs and are thus applicable in different institutions. The validation results seem promising and omission of completion ALND might be considered in patients with the probability of having non-SLN metastases of 10% or less.
Literatur
1.
Zurück zum Zitat Fleissig A, Fallowfield LJ, Langridge CI et al (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95:279–293CrossRefPubMed Fleissig A, Fallowfield LJ, Langridge CI et al (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95:279–293CrossRefPubMed
2.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553CrossRefPubMed Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553CrossRefPubMed
3.
Zurück zum Zitat Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106:4–16CrossRefPubMed Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106:4–16CrossRefPubMed
4.
Zurück zum Zitat Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113–119CrossRefPubMed Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113–119CrossRefPubMed
5.
Zurück zum Zitat Degnim AC, Reynolds C, Pantvaidya G et al (2005) Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190:543–550CrossRefPubMed Degnim AC, Reynolds C, Pantvaidya G et al (2005) Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190:543–550CrossRefPubMed
6.
Zurück zum Zitat Hwang RF, Krishnamurthy S, Hunt KK et al (2003) Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248–254CrossRefPubMed Hwang RF, Krishnamurthy S, Hunt KK et al (2003) Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248–254CrossRefPubMed
7.
Zurück zum Zitat Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66–80CrossRefPubMed Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66–80CrossRefPubMed
8.
Zurück zum Zitat Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95:302–309CrossRefPubMed Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95:302–309CrossRefPubMed
9.
Zurück zum Zitat Saidi RF, Dudrick PS, ReMine SG, Mittal VK (2004) Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 70:101–105PubMed Saidi RF, Dudrick PS, ReMine SG, Mittal VK (2004) Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 70:101–105PubMed
10.
Zurück zum Zitat Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140–1151CrossRefPubMed Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140–1151CrossRefPubMed
11.
Zurück zum Zitat Coutant C, Olivier C, Lambaudie E et al (2009) Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 27:2800–2808CrossRefPubMed Coutant C, Olivier C, Lambaudie E et al (2009) Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 27:2800–2808CrossRefPubMed
12.
Zurück zum Zitat Zgajnar J, Perhavec A, Hocevar M et al (2007) Low performance of the MSKCC nomogram in preoperatively ultrasonically negative axillary lymph node in breast cancer patients. J Surg Oncol 96:547–553CrossRefPubMed Zgajnar J, Perhavec A, Hocevar M et al (2007) Low performance of the MSKCC nomogram in preoperatively ultrasonically negative axillary lymph node in breast cancer patients. J Surg Oncol 96:547–553CrossRefPubMed
13.
Zurück zum Zitat Zgajnar J, Besic N, Podkrajsek M, Hertl K, Frkovic-Grazio S, Hocevar M (2005) Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes. Eur J Cancer 41:244–248CrossRefPubMed Zgajnar J, Besic N, Podkrajsek M, Hertl K, Frkovic-Grazio S, Hocevar M (2005) Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes. Eur J Cancer 41:244–248CrossRefPubMed
14.
Zurück zum Zitat Zgajnar J, Hocevar M, Podkrajsek M et al (2006) Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients. Breast Cancer Res Treat 97:293–299CrossRefPubMed Zgajnar J, Hocevar M, Podkrajsek M et al (2006) Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients. Breast Cancer Res Treat 97:293–299CrossRefPubMed
15.
Zurück zum Zitat Samphao S, Eremin JM, El-Sheemy M, Eremin O (2008) Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach. Ann Surg Oncol 15:1282–1296CrossRefPubMed Samphao S, Eremin JM, El-Sheemy M, Eremin O (2008) Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach. Ann Surg Oncol 15:1282–1296CrossRefPubMed
16.
Zurück zum Zitat Podkrajsek M, Music MM, Kadivec M et al (2005) Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol 15:1044–1050CrossRefPubMed Podkrajsek M, Music MM, Kadivec M et al (2005) Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol 15:1044–1050CrossRefPubMed
17.
Zurück zum Zitat Zgajnar J, Frkovic-Grazio S, Besic N et al (2004) Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients–results of a large series. J Surg Oncol 85:82–86CrossRefPubMed Zgajnar J, Frkovic-Grazio S, Besic N et al (2004) Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients–results of a large series. J Surg Oncol 85:82–86CrossRefPubMed
18.
Zurück zum Zitat Harrell FE (2001) Regression modeling strategies. Springer, New York Harrell FE (2001) Regression modeling strategies. Springer, New York
19.
Zurück zum Zitat Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–7720CrossRefPubMed Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–7720CrossRefPubMed
20.
Zurück zum Zitat Aihara T, Munakata S, Morino H, Takatsuka Y (2004) Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann Surg Oncol 11:747–750CrossRefPubMed Aihara T, Munakata S, Morino H, Takatsuka Y (2004) Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann Surg Oncol 11:747–750CrossRefPubMed
21.
Zurück zum Zitat Brogi E, Torres-Matundan E, Tan LK, Cody HS III (2005) The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients. Ann Surg Oncol 12:173–180CrossRefPubMed Brogi E, Torres-Matundan E, Tan LK, Cody HS III (2005) The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients. Ann Surg Oncol 12:173–180CrossRefPubMed
22.
Zurück zum Zitat Lambert LA, Ayers GD, Hwang RF et al (2006) Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13:310–320CrossRefPubMed Lambert LA, Ayers GD, Hwang RF et al (2006) Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13:310–320CrossRefPubMed
23.
Zurück zum Zitat Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE (1999) Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229:536–541CrossRefPubMed Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE (1999) Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229:536–541CrossRefPubMed
24.
Zurück zum Zitat Kamath VJ, Giuliano R, Dauway EL et al (2001) Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 136:688–692CrossRefPubMed Kamath VJ, Giuliano R, Dauway EL et al (2001) Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 136:688–692CrossRefPubMed
25.
Zurück zum Zitat Reynolds C, Mick R, Donohue JH et al (1999) Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17:1720–1726PubMed Reynolds C, Mick R, Donohue JH et al (1999) Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17:1720–1726PubMed
26.
Zurück zum Zitat Viale G, Maiorano E, Mazzarol G et al (2001) Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92:1378–1384CrossRefPubMed Viale G, Maiorano E, Mazzarol G et al (2001) Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92:1378–1384CrossRefPubMed
27.
Zurück zum Zitat Weiser MR, Montgomery LL, Tan LK et al (2001) Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 8:145–149CrossRefPubMed Weiser MR, Montgomery LL, Tan LK et al (2001) Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 8:145–149CrossRefPubMed
28.
Zurück zum Zitat Perhavec A, Besic N, Hocevar M, Zgajnar J (2008) Touch imprint cytology of the sentinel lymph nodes might not be indicated in early breast cancer patients with ultrasonically uninvolved axillary lymph nodes. Ann Surg Oncol 15:2257–2262CrossRefPubMed Perhavec A, Besic N, Hocevar M, Zgajnar J (2008) Touch imprint cytology of the sentinel lymph nodes might not be indicated in early breast cancer patients with ultrasonically uninvolved axillary lymph nodes. Ann Surg Oncol 15:2257–2262CrossRefPubMed
29.
Zurück zum Zitat Poirier E, Sideris L, Dube P, Drolet P, Meterissian SH (2008) Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the canadian experience. Ann Surg Oncol 15:2562–2567CrossRefPubMed Poirier E, Sideris L, Dube P, Drolet P, Meterissian SH (2008) Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the canadian experience. Ann Surg Oncol 15:2562–2567CrossRefPubMed
30.
Zurück zum Zitat Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888CrossRefPubMed Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888CrossRefPubMed
31.
Zurück zum Zitat Rutgers EJ (2008) Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol 26:698–702CrossRefPubMed Rutgers EJ (2008) Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol 26:698–702CrossRefPubMed
32.
Zurück zum Zitat Fant JS, Grant MD, Knox SM et al (2003) Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 10:126–130CrossRefPubMed Fant JS, Grant MD, Knox SM et al (2003) Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 10:126–130CrossRefPubMed
33.
Zurück zum Zitat Guenther JM, Hansen NM, DiFronzo LA et al (2003) Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003(138):52–56 Guenther JM, Hansen NM, DiFronzo LA et al (2003) Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003(138):52–56
34.
Zurück zum Zitat Hwang RF, Gonzalez-Angulo AM, Yi M et al (2007) Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110:723–730CrossRefPubMed Hwang RF, Gonzalez-Angulo AM, Yi M et al (2007) Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110:723–730CrossRefPubMed
35.
Zurück zum Zitat Jeruss JS, Winchester DJ, Sener SF et al (2005) Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 12:34–40CrossRefPubMed Jeruss JS, Winchester DJ, Sener SF et al (2005) Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 12:34–40CrossRefPubMed
36.
Zurück zum Zitat Langer I, Marti WR, Guller U et al (2005) Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241:152–158PubMed Langer I, Marti WR, Guller U et al (2005) Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241:152–158PubMed
37.
Zurück zum Zitat Naik AM, Fey J, Gemignani M et al (2004) The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240:462–468CrossRefPubMed Naik AM, Fey J, Gemignani M et al (2004) The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240:462–468CrossRefPubMed
38.
Zurück zum Zitat Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106PubMed Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106PubMed
Metadaten
Titel
Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node
verfasst von
Andraž Perhavec
Maja Pohar Perme
Marko Hočevar
Nikola Besić
Janez Žgajnar
Publikationsdatum
01.01.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0561-4

Weitere Artikel der Ausgabe 2/2010

Breast Cancer Research and Treatment 2/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.